Evidence map›Paper›PMID 34867813›Full record

ArticleFrontiers in endocrinology2021

Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture.

Simone Paterni, Chukwuma Okoye, Alessia M Calabrese, Filippo Niccolai, Antonio Polini, Nadia Caraccio, Valeria Calsolaro, Fabio Monzani

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Preoperative Thyroid-Stimulating Hormone Levels and Three-Year Mortality in Elderly Hip Fracture Patients: Insights from a Prospective Cohort Study.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  5. Assessing patient information needs for new antidiabetic medications to inform shared decision-making: A best-worst scaling experiment in China.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Simone PaterniGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Chukwuma OkoyeGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Alessia M CalabreseGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Filippo NiccolaiGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Antonio PoliniGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Nadia CaraccioGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Valeria CalsolaroGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Fabio MonzaniGeriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
University of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies have shown increased risk of fracture in older patients with poor or strict glycemic control (glycated hemoglobin, HbA1c, ≥ 8% or < 6-7% respectively); however, these reports did not investigate the oldest-old population. Comprehensive geriatric assessment (CGA) and a patient-centered approach have been proven to improve the quality of care in the management of Type 2 Diabetes Mellitus (T2DM) in the older patients, but data regarding T2DM in patients with fragility fractures are still lacking. Aim: To investigate the prognostic role of HbA1c and frailty level in older diabetic patients admitted for hip fracture. Methods: Prospective observational cohort study conducted on diabetic geriatric patients consecutively hospitalized for hip fracture in the orthogeriatric unit of a tertiary care hospital. Preoperative comprehensive geriatric assessment (CGA) was performed. Using the Clinical Frailty Scale (CFS), diabetic patients were categorized in robust (CFS < 5) and frail (CFS ≥ 5), and further stratified according to HbA1c values [Tertile 1 (T1) HbA1c < 48 mmol/mol, Tertile 2 (T2) 48-58 mmol/mol and Tertile 3 (T3) > 58 mmol/mol). Comparisons between continuous variables were performed with analysis of non-parametric test for independent samples, while relationships between categorical variables were assessed by chi-square test. Using logistic multivariate regression, we evaluated the determinants of 1-year all-cause mortality in diabetic older patients with hip fracture. Results: Among the 1319 older patients (mean age 82.8 ± 7.5 years, 75.9% females) hospitalized for hip fracture, 204 (15.5%) had a previous diagnosis of T2DM. T2DM patients showed an increased proportion of multiple concurrent fractures occurred during the accidental fall or syncope (12.7% Conclusions: Frail patients with HbA1c ≥ 48 mmol/L showed an increased mortality risk as compared to robust counterparts. CFS represents an important tool to select diabetic subjects with higher likelihood of adverse outcome.

Indexed as

Frail ElderlyAgedAged, 80 and overDiabetes Mellitus, Type 2FemaleGeriatric AssessmentGlycated HemoglobinHip FracturesHumansMalePrognosisProspective StudiesGlycated Hemoglobinfrailtyglycated hemoglobinHbA1chip fractureolder patientT2DM

Identifiers

PMID34867813
PMCPMC8637116
OpenAlexW3217602979

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.